Portrait of Fallon, Patrick

Fallon, Patrick

U.S. Representative TX-4 Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
176
Buys / sells
35% / 64%
Last trade
Oct 31, 2022
Last filing
Dec 1, 2022

Latest disclosed trades

Latest 10 of 176
Ticker Type Traded
TWTR Sell Oct 31, 2022
TWTR Buy Jan 24, 2022
TWTR Buy Jan 19, 2022
VZ Sell Jan 7, 2022
TWTR Sell Dec 16, 2021
TWTR Buy Dec 16, 2021
ORCC Buy Nov 30, 2021
TWTR Buy Nov 19, 2021
LUV Buy Nov 19, 2021
PYPL Buy Nov 19, 2021

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Fallon, Patrick stock trade activity

FilingIQ has indexed 176 congressional stock trade disclosures for Fallon, Patrick. The most recent disclosed transaction is dated Oct 31, 2022.

Across the full history, 62 purchases and 113 sales have been disclosed under the STOCK Act.

Top tickers traded by Fallon, Patrick

Frequently asked

How many stock trades has Fallon, Patrick disclosed?
FilingIQ tracks 176 Periodic Transaction Report disclosures for Fallon, Patrick, with the most recent dated Oct 31, 2022. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Fallon, Patrick a net buyer or net seller?
Across the disclosed trade history, 62 (35%) were purchases and 113 (64%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Fallon, Patrick come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.